title: Retinoids, a new class of compounds with prophylactic and therapeutic activities in oncology and dermatology.
abstract: A review of recent investigations in the retinoid field is presented. Retinoic acid exerts a prophylactic and a therapeutic effect on chemically induced benign and malignant epithelial tumors in mice. In clinical studies positive therapeutic results have been obtained in patients with preneoplastic and neoplastic epithelial lesions. However, treatment with retinoic acid is limited by serious side effects (hypervitaminosis A syndrome). Therefore, the synthesis of analogs of retinoic acid (retinoids) possessing a more favorable therapeutic ratio has been initiated. Among a large series of synthesized compounds, certain aromatic analogs proved to have a particularly favorable therapeutic ratio. The structure-activity relationship of the most active retinoids is discussed including some biological data concerning prophylaxis and therapy of epithelial tumors. The total synthesis of retinoids according to various building schemes is discussed in detail. Methods for the synthesis of the cyclic end group, of the polyene chain component, and of the full retinoid skeleton are described. Metabolic studies of retinoic acid and of the most active retinoid, as well as the synthesis of some isolated metabolites are outlined. Suggestions concerning the mechanism of action of retinoids are made. Some clinical results on the treatment of acne, psoriasis and precancerous conditions are reported.
mesh_terms: D000818:Animals; D002277:Carcinoma / Q000188:drug therapy; D006801:Humans; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010212:Papilloma / Q000188:drug therapy; D012172:Retinaldehyde / Q000627:therapeutic use; D012871:Skin Diseases / Q000188:drug therapy* / Q000517:prevention & control; D012878:Skin Neoplasms / Q000188:drug therapy*; D013329:Structure-Activity Relationship; D014212:Tretinoin / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use; D014801:Vitamin A / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D014801:Vitamin A; D014212:Tretinoin; D012172:Retinaldehyde